P3 OA by SIPRES SRL / CONTRAD SWISS SA

P3 OA by

Drug Labeling and Warnings

P3 OA by is a Otc medication manufactured, distributed, or labeled by SIPRES SRL, CONTRAD SWISS SA. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

P3 OA- p3 oa gel 
SIPRES SRL

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredients

Saccharomyces Cerevisiae

Glycerin

Purpose

Pre and post regenerative skin protectant topical

For the temporary relief of moderate aches and pains of muscles and joints associated with Osteoarthritis

Uses

Apply the monodose gel on a patch gauze to clean dry skin. Place the patch on the affected area. Wear the patch for 4-8 hours.

Warnings

For External Use Only

For External Use Only

Do not use other creams or cosmetics with the monodose.

Do not get the area wet once the patch is in place.

Avoid contact with eyes

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Stop use and ask doctor if

Condition Worsens
Symptoms last more than 7 days

Directions

Apply as needed.

Children under 6 months: ask a doctor

Apply the monodose gel on a patch gauze to clean dry skin. Place the patch on the affected area. Wear the patch for 4-8 hours.

Other information

Store at room temperature 20-25◦C (68-77◦F) in a dry place, out of direct sunlight.

Inactive ingredients

Aqua, Benzoic acid, Carbomer, Dehydroacetic acid, Disodium EDTA, Ethylhexylglycerin, Panthenol, PEG-40 hydrogenated castor oil, Phenoxyethanol, Propylene glycol, Sodium hyaluronate, Sodium hydroxide, Xanthan gum

Questions

@ info@contrad.ch

Principal Display Panel

Secondary Pack

P3 OA 
p3 oa gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 52371-010
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SACCHAROMYCES CEREVISIAE (UNII: 978D8U419H) (SACCHAROMYCES CEREVISIAE - UNII:978D8U419H) SACCHAROMYCES CEREVISIAE0.089 g  in 100 g
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN10 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
PANTHENOL (UNII: WV9CM0O67Z)  
WATER (UNII: 059QF0KO0R)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER (UNII: 788QAG3W8A)  
CARBOMER 934 (UNII: Z135WT9208)  
PEG-40 CASTOR OIL (UNII: 4ERD2076EF)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
MAGNESIUM DISODIUM EDTA (UNII: NDT563S5VZ)  
XANTHAN GUM (UNII: TTV12P4NEE)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 52371-010-011 in 1 CARTON11/08/2021
11 in 1 VIAL, SINGLE-USE
11.8 g in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34711/08/202102/28/2022
Labeler - SIPRES SRL (440712842)
Registrant - CONTRAD SWISS SA (486203529)
Establishment
NameAddressID/FEIBusiness Operations
SIPRES SRL440712842manufacture(52371-010)

Revised: 7/2022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.